{{medical}}
{{drugbox
| verifiedrevid = 443852402
| IUPAC_name = 2-溴-2-氯-1,1,1-三氟乙烷<br>(2-Bromo-2-chloro-1,1,1-trifluoroethane）
| image = Halothane.svg
| width = 120px
| image2 = Halothane-3D-vdW.png
| width2 = 120px

<!--Clinical data-->
| Drugs.com = {{drugs.com|CONS|halothane}}
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = [[肝脏|肝脏]] (CYP2E1<ref>[http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00598.txt DrugBank: DB01159 (Halothane)<!-- Bot generated title -->]</ref>)
| elimination_half-life = 
| excretion = 肾脏

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 151-67-7
| ATC_prefix = N01
| ATC_suffix = AB01
| ATC_supplemental = 
| PubChem = 3562
| IUPHAR_ligand = 2401
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01159
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3441
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UQT9G45D1P
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00542
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 5615
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 931

<!--Chemical data-->
| C=2 | H=1 | Br=1 | Cl=1 | F=3 
| molecular_weight = 197.381 g/mol
| smiles = C(C(F)(F)F)(Cl)Br
| InChI = 1/C2HBrClF3/c3-1(4)2(5,6)7/h1H
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BCQZXOMGPXTTIC-UHFFFAOYSA-N
}}

'''氟烷'''，IUPAC命名法命名为'''2-溴-2-氯-1,1,1-三氟乙烷'''（英语名：'''Halothane'''，英语商品名：'''Fluothane'''），分子式为C<sub>2</sub>HBrClF<sub>3</sub>，唯一一种含有溴原子的吸入性[[全身麻醉剂|全身麻醉剂]]。它是一种无色的、有令人愉快气味的液体，在光照的环境下不稳定，需在深色瓶中储存并加入0.01%的[[百里酚|百里酚]]作为稳定剂。氟烷已被列入[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]。<ref name="essentialWHO">{{cite web
 | year = March 2011
 | url = http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf
 | title = WHO Model List of Essential Medicines
 | format = PDF
 | publisher = World Health Organization
 | accessdate = 2011-08-22
}}</ref>

==历史==
1951年，[[帝国化学工业|帝国化学工业]]有限公司的Charles Suckling首先合成出了氟烷。1956年，M. Johnstone在[[曼彻斯特|曼彻斯特]]首次将氟烷用于临床，此后由于氟烷不易燃，临床使用相比易燃的吸入性全身麻醉剂[[乙醚|乙醚]]和[[环丙烷|环丙烷]]更安全，所以迅速替代乙醚和环丙烷成为临床使用更受欢迎的吸入性[[全身麻醉剂|全身麻醉剂]]。

==合成方法==
工业上以[[三氯乙烯|三氯乙烯]]为原料。先在130℃的条件下，用[[路易斯酸|路易斯酸]][[三氯化锑|三氯化锑]]催化[[氟化氢|氟化氢]]对三氯乙烯的[[加成反应|加成反应]]得到合成中间体2-氯-1,1,1-三氟乙烷，接着2-氯-1,1,1-三氟乙烷在450℃的高温下与单质[[溴|溴]]发生取代反应得到氟烷<ref>{{Cite patent | country = US | number = 2921098 | status = granted | title = PROCESS FOR THE PREPARATION OF 1,1,1-TRIFLUORO-2-BROMO-2-CHLOROETHANE | pubdate = 1958-06-30 | gdate =  January 1960 | pridate= 1954-08-20 | inventor = Suckling et al. | assign1= Imperial Chemical Industries | google_patent_id = 6JpaAAAAEBAJ }}</ref>。

==参考资料==
{{reflist}}

==拓展阅读==
*Atkinson, Rushman, Lee. ''A Synopsis of Anaesthesia''. 1987.
*Eger, Eisenkraft, Weiskopf. ''The Pharmacology of Inhaled Anesthetics''. 2003.

{{Authority control}}
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:麻醉药品|Category:麻醉药品]]
[[Category:氯氟烃|Category:氯氟烃]]
[[Category:溴代烃|Category:溴代烃]]
[[Category:三氟甲基化合物|Category:三氟甲基化合物]]

{{解剖学治疗学及化学分类系统}}
{{General anesthetics}}